Sichuan Duorui Biopharmaceutical Co., Ltd.

Sichuan Frontier Biopharmaceutical Co., Ltd. was established in 2018 and changed its name to Sichuan Duorui Pharmaceutical Co., Ltd. in 2024. Located in Chengdu-Aba Industrial Concentrated Development Zone, Jintang County, Chengdu City, Sichuan Province. It focuses on the R&D and production of peptides and Oligonucleotide APIs. The main products are Lanreotide Acetate, Semaglutide, Tirzepatide, Retatrutide Pegcetacoplan, and so on.